International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors.
Int Forum Allergy Rhinol
; 14(2): 149-608, 2024 Feb.
Article
in En
| MEDLINE
| ID: mdl-37658764
Key words
adenocarcinoma; adenoid cystic carcinoma; adjuvant therapy; angiofibroma; biopsy; chemotherapy; concurrent; endoscopic endonasal approach; esthesioneuroblastoma; evidence-based medicine; head and neck cancer; head and neck oncology; immunotherapy; induction chemotherapy; inverted papilloma; lymphoma; margins; metastases; mucosal melanoma; nasopharyngeal carcinoma; neoadjuvant therapy; neuroectodermal carcinoma; neuroendocrine carcinoma; olfactory neuroblastoma; open approach; orbit; papilloma; quality of life; radiation; resectability; rhabdomyosarcoma; risk factors; sarcoma; sinonasal cancer; sinonasal malignancy; sinonasal neoplasm; sinonasal oncology; sinonasal papilloma; sinonasal tumor; sinonasal undifferentiated carcinoma; skull base; squamous cell carcinoma; surgery; surveillance; survival; survivorship
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Paranasal Sinus Neoplasms
/
Head and Neck Neoplasms
/
Hypersensitivity
Type of study:
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
Int Forum Allergy Rhinol
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: